Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Semin Intervent Radiol ; 37(1): 97-102, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32139975

ABSTRACT

The spleen is the most commonly injured organ after blunt abdominal trauma. Nonoperative management with splenic arterial embolization (SAE) is the current standard of care for hemodynamically stable patients. Current data favor the use of proximal and coil embolization techniques in adults, while observation is suggested in the pediatric population. In this review, the authors describe the most recent evidence informing the clinical indications, techniques, and complications for SAE.

2.
Obes Surg ; 28(3): 725-734, 2018 03.
Article in English | MEDLINE | ID: mdl-28861731

ABSTRACT

PURPOSE: Ileal interposition recapitulates many of the metabolic improvements similar to Roux-en-Y gastric bypass. We aimed to determine whether the metabolic improvements seen following ileal interposition were conferred solely by the interposed segment by examining changes in neighboring intestinal segments as well as the composition of the bile acid pool. MATERIALS AND METHODS: Adult male rats were treated with either sham or ileal interposition surgeries. Glucose tolerance tests, body composition analysis, polymer chain reaction, enzyme-linked immunosorbent assay, and mass spectrometry were done after the surgeries. RESULTS: This study showed that ileal interposition improved glucose tolerance and enhanced both fasting and glucose-stimulated GLP-1 secretion in diabetic rats. Total bile acid pool was similar between groups but the composition favored glycine-conjugation in rats with ileal interposition. Insulin secretion was highly correlated with the 12-alpha-hydroxylase index of activity. The interposed ileum exhibited an increase in mRNA for preproglucagon and peptide YY; however, the bile acid transporter, apical sodium bile acid transporter, was dramatically reduced compared to sham rats. The interposed segment becomes jejunized in its new location as indicated by an increase in Glut2 and Pepck mRNA, genes predominantly synthesized within the jejunum. CONCLUSION: Ileal relocation alone can significantly alter the bile acid pool to favor a more insulin-sensitive metabolism in association with intestinal wide alterations in mRNA for a variety of genes. Ileal interposition may confer metabolic improvement via both the interposed segment and the associated intestinal changes in all segments of the intestine, including the colon.


Subject(s)
Adaptation, Physiological/genetics , Bile Acids and Salts/metabolism , Ileum/physiopathology , Insulin Resistance/genetics , Intestines/physiopathology , Adaptation, Physiological/physiology , Animals , Diabetes Mellitus, Experimental/surgery , Disease Models, Animal , Glucose/metabolism , Ileum/surgery , Insulin/metabolism , Insulin Resistance/physiology , Intestinal Mucosa/metabolism , Intestines/surgery , Male , Obesity, Morbid/metabolism , Obesity, Morbid/surgery , Rats
3.
J Neurointerv Surg ; 7(6): 463-70, 2015 Jun.
Article in English | MEDLINE | ID: mdl-24811743

ABSTRACT

BACKGROUND: N-Butyl cyanoacrylate (NBCA) is an adhesive liquid embolic agent widely used for embolization of cranial, head and neck tumors. Adequate distal penetration of NBCA into vessels with the smallest possible diameter, while preventing its reflux, is still a challenge, even in experienced hands. Simultaneous infusion of 5% dextrose in water solution (D5W) through the guiding catheter has been described before as a technique for improving embolization of dural arteriovenous malformations. OBJECTIVE: To describe our experience with a modified D5W guide catheter push technique during embolization of hemorrhagic cranial, head and neck tumors. The embolization technique and pitfalls which might lead to complications are discussed in detail. MATERIALS: A retrospective series of 20 patients treated with the D5W push technique during embolization of cranial, head and neck lesions between 2007 and 2013 is presented. The goal of embolization was preoperative or palliative embolization of hemorrhagic tumors. Localization and histopathologic diagnosis of lesions, concentration of NBCA used, subsequent surgical treatment, intraoperative blood loss, and complications were evaluated. RESULTS: A total of 44 arterial pedicles were embolized during 22 treatment sessions. Adequate embolization of the lesions was achieved in all cases. Transient ischemic attack due to atheroma embolization (from the aorta) was seen in one patient (4%). Persistent vascularity of tumor associated with minimal intraoperative bleeding was reported in one patient (4%). Recurrence of epistaxis was reported in two patients diagnosed with Osler-Weber-Rendu syndrome. CONCLUSIONS: The D5W push technique during NBCA embolization of cranial, head and neck tumors is a safe and effective method to enhance penetration of the embolizing agent.


Subject(s)
Brain Neoplasms/therapy , Embolization, Therapeutic/methods , Enbucrilate/therapeutic use , Glucose/administration & dosage , Head and Neck Neoplasms/therapy , Aged, 80 and over , Embolization, Therapeutic/adverse effects , Embolization, Therapeutic/instrumentation , Humans , Middle Aged , Treatment Outcome , Vascular Access Devices
4.
Surg Neurol Int ; 5(Suppl 4): S155-60, 2014.
Article in English | MEDLINE | ID: mdl-25071939

ABSTRACT

BACKGROUND: Management of aneurysms associated with deep collateral vessels in moyamoya disease is challenging both from an endovascular and a surgical standpoint. Difficulties with access or localization, and compromise of the collateral circulation with subsequent ischemia are the primary concerns, making direct obliteration potentially unfeasible or risky. Alternatively, superficial temporal artery-middle cerebral artery bypass is another potential strategy for resolution of these aneurysms. CASE DESCRIPTION: Presented are the findings and management for a patient with moyamoya disease and bilateral deep collateral vessel aneurysms, successfully treated with endovascular obliteration following a right-sided hemorrhage and subsequently with bypass for an unruptured but growing contralateral aneurysm. CONCLUSIONS: A rationale and approach to management is outlined, as derived from review of the current literature and the illustrative case with bilateral collateral vessel aneurysms.

5.
Am J Kidney Dis ; 64(2): 198-203, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24656452

ABSTRACT

BACKGROUND: Retinopathy is associated with increased mortality risk in general populations. We evaluated the joint effect of retinopathy and chronic kidney disease (CKD) on mortality in a representative sample of U.S. adults. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 7,640 adults from NHANES (National Health and Nutrition Examination Survey) 1988-1994 with mortality linkage through December 31, 2006. PREDICTORS: CKD, defined as low estimated glomerular filtration rate (<60 mL/min/1.73 m2) or albuminuria (urine protein-creatinine ratio ≥30 mg/g), and retinopathy, defined as the presence of microaneurysms, hemorrhages, exudates, microvascular abnormalities, or other evidence of diabetic retinopathy by fundus photograph. OUTCOMES: All-cause and cardiovascular mortality. MEASUREMENTS: Multivariable-adjusted Cox proportional hazards. RESULTS: Overall, 4.6% of participants had retinopathy and 15% had CKD. Mean age was 56 years, 53% were women, and 81% were non-Hispanic whites. The prevalence of retinopathy in patients with CKD was 11%. We identified 2,634 deaths during 14.5 years' follow-up. In multivariable analyses, compared with individuals with neither CKD nor retinopathy, HRs for all-cause mortality were 1.02 (95% CI, 0.75-1.38), 1.52 (95% CI, 1.35-1.72), and 2.39 (95% CI, 1.77-3.22) for individuals with retinopathy only, those with CKD only, and those with both CKD and retinopathy, respectively. Corresponding HRs for cardiovascular mortality were 0.96 (95% CI, 0.50-1.84), 1.72 (95% CI, 1.47-2.00), and 2.96 (95% CI, 2.11-4.15), respectively. There was a significant synergistic interaction between retinopathy and CKD on all-cause mortality (P=0.04). LIMITATIONS: The presence of retinopathy was evaluated only once. Small sample size of some of the subpopulations studied. CONCLUSIONS: In the presence of CKD, retinopathy is a strong predictor of mortality in this adult population.


Subject(s)
Cardiovascular Diseases/mortality , Hypertensive Retinopathy/mortality , Nutrition Surveys/trends , Randomized Controlled Trials as Topic/trends , Renal Insufficiency, Chronic/mortality , Aged , Cardiovascular Diseases/diagnosis , Cohort Studies , Female , Follow-Up Studies , Humans , Hypertensive Retinopathy/diagnosis , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Renal Insufficiency, Chronic/diagnosis
6.
Obes Surg ; 19(1): 96-104, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18989728

ABSTRACT

BACKGROUND: The surgical treatment for obesity promotes massive weight loss and early improvement in co-morbid conditions such as type-2 diabetes. Because surgically mediated glycemic improvements are immediate, the mechanisms involved appear to be weight loss independent. Ileal interposition has been used to gain understanding of the relative role that the lower intestine plays in mediating metabolic improvement. Here, we report that ileal interposition is sufficient for improving glucose tolerance in a low-dose streptozotocin-treated diabetic rat model as well as in normal rats with no effect on body weight. METHODS: Male Long-Evans rats were treated with streptozotocin (35 mg/kg) or left untreated and then received sham or ileal interposition. Body weight was measured as well as glucose and insulin tolerance. Plasma insulin and gut hormones were measured during the glucose tolerance test. RESULTS: Streptozotocin treatment resulted in hyperglycemia within 48 h after treatment. Diabetic rats with ileal interposition showed improvement in glucose tolerance as early as 4 weeks after surgery compared to sham (p < 0.05). By 11 weeks after surgery glucose and insulin tolerance was markedly improved in interposed-diabetic compared to sham-diabetic rats (p < 0.05). Normal non-diabetic rats showed improved glucose tolerance after ileal interposition compared to sham (p < 0.05). Insulin secretion was increased in interposed rats following glucose administration (p < 0.05). The ileal-derived hormones glucagon like peptide-1 (GLP-1), peptide YY (PYY), and glucagon were all significantly elevated in the ileal interposed rats (p < 0.01). Gastric inhibitory polypeptide (GIP) was unchanged. In neither study did body weight between the surgical groups differ at any time point. CONCLUSIONS: Ileal interposition effectively improves glucose tolerance in streptozotocin-diabetic and euglycemic rats. Enhanced insulin secretion can explain the lowered glucose concentrations in euglycemic rats following ileal interposition. Ileal interposition is associated with dramatically elevated ileal hormones, GLP-1, PYY, and glucagon (p < 0.01) with no change in the duodenal hormone GIP.


Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/surgery , Glucose Intolerance/prevention & control , Jejunoileal Bypass , Animals , Diabetes Mellitus, Experimental/etiology , Gastrointestinal Hormones/blood , Glucose Intolerance/etiology , Glucose Tolerance Test , Male , Pancreatic Hormones/blood , Rats , Rats, Long-Evans , Streptozocin
7.
Am J Physiol Regul Integr Comp Physiol ; 295(6): R1747-53, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18922963

ABSTRACT

Agouti-related peptide (AgRP), the endogenous antagonist to the melanocortin 3 and 4 receptors, elicits robust hyperphagia and weight gain in rodents when administered directly into the central nervous system. The relative influence of AgRP to cause weight gain in rodents partially depends on the activity level of the melanocortin agonist-producing proopiomelanocortin neurons. Both proopiomelanocortin and AgRP neurons within the arcuate nucleus receive energy storage information from circulating peripheral signals such as leptin and insulin. Another modulator of AgRP activity includes the cell surface molecule syndecan-3. Because leptin and insulin affect food intake in a sexually dimorphic way in rodents and syndecan-3-deficient mice regulate adiposity levels through distinct physiological mechanisms, we hypothesized that AgRP-induced weight gain would also be sexually dimorphic in rats. In the present study, the behavioral and physiological effects of centrally-administered AgRP in male and female were investigated. In male rats, AgRP (1 nmol) induced 5 days (P < 0.0001) of significantly elevated feeding compared with vehicle-treated controls, while females displayed 3 days of hyperphagia (P < 0.05). However, 1 wk after the injection, both male and female rats gained the same percent body weight (6%). Interestingly, female rats exhibited a greater reduction in energy expenditure (Vo2) following AgRP compared with male rats (P < 0.05). Removal of the gonads did not alter cumulative food intake in male or female rats but did attenuate the dramatic reduction in Vo2 exhibited by females. Both intact and gonadectomized rats demonstrated significantly increased respiratory quotient supporting the anabolic action of AgRP (P < 0.01). These findings are novel in that they reveal sex-specific underlying physiology used to achieve weight gain following central AgRP in rats.


Subject(s)
Agouti-Related Protein/metabolism , Orchiectomy , Ovariectomy , Weight Gain , Agouti-Related Protein/administration & dosage , Animals , Eating , Energy Metabolism , Female , Hyperphagia/metabolism , Injections, Intraventricular , Male , Oxygen Consumption , Rats , Rats, Long-Evans , Sex Factors , Time Factors , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...